Type Whole antibody ATC code none | Trade names Aurexis CAS Number 521079-87-8 | |
Tefibazumab (named Aurexis but not approved) is a humanized monoclonal antibody for the treatment of severe infections with Staphylococcus aureus. Possible indications include the treatment of S. aureus in a phase 2a patients with cystic fibrosis and of methicillin-resistant S. aureus.
It was developed by Inhibitex.
References
Tefibazumab Wikipedia(Text) CC BY-SA